Broach Lifecare Hospital Ltd (BROACH) is currently trading at 12.70 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Broach Lifecare Hospital Limited operates boutique cardiac hospitals under the Maple Hospitals brand, having converted from a private to a public company after acquiring Dr. Vyas's Heart Hospital and Dr. Vyas Hospital; core services include non-invasive cardiology diagnostics and a full interventional cardiology suite introduced in June 2023. Financially the company reported Total Income of Rs. 603.67 lakhs for the year ended March 31, 2026, up from Rs. 322.52 lakhs the prior year, while reported net profit after tax fell sharply to Rs. 8.68 lakhs for FY2026 from Rs. 53.59 lakhs, reflecting revenue growth with margin pressure and H2 volatility. Capital intensity increased materially in FY2026: Property, Plant & Equipment rose to Rs. 454.60 lakhs and the cashflow statement records a purchase of fixed assets of Rs. 130.31 lakhs, funded alongside an IPO that raised Rs. 4.02 crores, signalling deliberate investments aimed at expanding clinical infrastructure and service capability. Corporate governance and reporting indicate basic compliance and oversight: audited standalone results for the half year and full year ended March 31, 2026 were issued with an unmodified opinion by K. K. Haryani & Co., the Board and Audit Committee reviewed results, and management issued statutory certifications under Regulation 33 declarations. Operationally Broach Lifecare strengthened its clinical services mix by adding interventional cardiac procedures — coronary angiography, PCI, pacemaker and device implantations, valvuloplasty and peripheral interventions — positioning the company as a focused cardiac care provider in Bharuch with integrated diagnostic and therapeutic capabilities.

Over the past 52 weeks, Broach Lifecare Hospital Ltd has traded between a low of ₹12.01 and a high of ₹20.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Broach Lifecare Hospital Ltd has a market capitalization of approximately 7.71. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Broach Lifecare Hospital Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -77.10 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 7.71 Cr, Broach Lifecare Hospital Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Broach Lifecare Hospital Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Broach Lifecare Hospital Ltd is -77.10. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.